{"id":"dexamethasone-pellet","safety":{"commonSideEffects":[{"rate":null,"effect":"Hyperglycemia"},{"rate":null,"effect":"Immunosuppression"},{"rate":null,"effect":"Hypertension"},{"rate":null,"effect":"Osteoporosis (with chronic use)"},{"rate":null,"effect":"Adrenal suppression"}]},"_chembl":{"chemblId":"CHEMBL1697787","moleculeType":"Small molecule","molecularWeight":"528.57"},"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Dexamethasone acts as a potent corticosteroid that inhibits phospholipase A2, reducing prostaglandin and leukotriene production, and suppresses T-cell and B-cell proliferation. The pellet formulation provides sustained or localized delivery of the active ingredient. It is commonly used to reduce inflammation and immune-mediated responses in various conditions.","oneSentence":"Dexamethasone is a synthetic glucocorticoid that suppresses the immune system and reduces inflammation by binding to glucocorticoid receptors.","_ai_confidence":"medium"},"_scrapedAt":"2026-03-27T23:44:23.386Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Inflammatory and immune-mediated conditions requiring localized or sustained corticosteroid delivery"}]},"trialDetails":[{"nctId":"NCT07233577","phase":"NA","title":"The Effect of Dexamethasone in Full Pulpotomy on Postoperative Pain in Permanent Molars","status":"COMPLETED","sponsor":"Cukurova University","startDate":"2024-12-18","conditions":"Pulpitis - Irreversible","enrollment":72},{"nctId":"NCT03629210","phase":"PHASE2","title":"Combination OZURDEX® & EyLea® vs. OZURDEX® Monotherapy in IncompLete-Responders wIth Diabetic Macular Edema","status":"WITHDRAWN","sponsor":"Pradeepa Yoganathan","startDate":"2019-09","conditions":"Diabetic Macular Edema","enrollment":""},{"nctId":"NCT02049476","phase":"PHASE4","title":"Study of the Effectiveness of Ozurdex for the Control of Uveitis","status":"COMPLETED","sponsor":"Johns Hopkins University","startDate":"2014-01","conditions":"Uveitis, Intermediate, Uveitis, Posterior","enrollment":20}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":4,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Ozurdex pellet"],"phase":"marketed","status":"active","brandName":"Dexamethasone pellet","genericName":"Dexamethasone pellet","companyName":"Johns Hopkins University","companyId":"johns-hopkins-university","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Dexamethasone is a synthetic glucocorticoid that suppresses the immune system and reduces inflammation by binding to glucocorticoid receptors. Used for Inflammatory and immune-mediated conditions requiring localized or sustained corticosteroid delivery.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}